Graeme is a molecular biologist who led the development of microbial sequencing technologies as CSO of Pathogenica, and commercialized multiplexed biomarker product lines as a Director at Firefly BioWorks, which was acquired by Abcam in 2015. Graeme’s postdoctoral training at MIT and Harvard Medical School focused on non-coding RNA biology, and he holds an MBiochem in Biochemistry and DPhil in Human Genetics from Oxford University.
Current role
Director, Product Development at Harvest Dental Products
Director, Product Development at Bolder Surgical
Director, Product Development at QuantCube Technology
Director, Product Development at Deccan International
Director, Product Development at Atomic Object